SLC2A4 and Insulin resistance: Treatment with LASSBio-2129 improved glucose tolerance, enhanced glycogen storage in skeletal muscle and liver, and increased GLUT4 mRNA expression, in addition to ameliorating insulin resistance in a dexamethasone-induced model.